Decrease of cardiovascular risk in patients with type 2 diabetes: review of the common strategies and clinical studies

Decrease of cardiovascular risk in patients with type 2 diabetes: review of the common strategies and clinical studies

Military Medical Academy of S.M. Kirov, Saint-Petersburg, Russia Recent clinical trials about the cardiovascular safety of empagliflozin and liraglutide demonstrated a convincing lowering effect on mortality from cardiovascular causes among the patients with type 2 diabetes. These findings resulted...

Full description

Bibliographic Details
Main Authors:	Vladimir V. Salukhov, Yurii Sh. Khalimov, Sergey B. Shustov, Dmitriy V. Kadin
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2018-08-01
Series:	Сахарный диабет
Subjects:	type 2 diabetes diabetic drugs insulin resistance cardiovascular risk cardioprotection cardiovascular outcomes
Online Access:	https://www.dia-endojournals.ru/jour/article/view/9570

Similar Items

The results and the meaning of EMPA-REG OUTCOME and LEADER studies for modern diabetology: in search of ideal combination
by: V. V. Salukhov
Published: (2019-08-01)

Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
by: Hanan Amadid, et al.
Published: (2022-11-01)

Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
by: Ehtasham Ahmad, et al.
Published: (2020-11-01)

Primary prevention of cardiovascular diseases in diabetes mellitus: 2020 strategy
by: V. I. Novikov, et al.
Published: (2020-05-01)

SGLT2 inhibitors and kidneys: mechanisms and main effects in diabetes mellitus patients
by: Vladimir V Salukhov, et al.
Published: (2021-01-01)

Cardioprotective measures in patients with cardiovascular risk factors and polymorbidity
by: article Editorial
Published: (2022-10-01)

Sodium-Glucose Co-Transporter 2 Inhibitors as a Powerful Cardioprotective and Renoprotective Tool: Overview of Clinical Trials and Mechanisms
by: Andrej Belančić, et al.
Published: (2023-07-01)

Progress on the pathogenesis of cardiovascular complications in patients with type 2 diabetes mellitus
by: ZHENG Tian-sheng, TONG Xue-wei, ZHANG Yi-tong, ZHU Min, ZHAN Xiao-rong
Published: (2022-05-01)

Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus
by: Vladimir V. Salukhov, et al.
Published: (2016-12-01)

The effect of empagliflozin on circulating endothelial progenitor cells in patients with diabetes and stable coronary artery disease
by: Roy Hershenson, et al.
Published: (2024-10-01)

Cardiovascular Effects of Metformin
by: B. T. Kurmanbekova, et al.
Published: (2022-03-01)

Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies
by: Nawfal Hasan Siam, et al.
Published: (2024-12-01)

Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease
by: M. Angelyn Bethel, et al.
Published: (2023-03-01)

Functional foods, cardiovascular disease and diabetes /
by: Arnold, A.
Published: (2004)

Cardiovascular disease and diabetes /
by: Clark, Luther T., et al.
Published: (2007)

Triglyceride-glucose (TyG) index is a predictor of arterial stiffness, incidence of diabetes, cardiovascular disease, and all-cause and cardiovascular mortality: A longitudinal two-cohort analysis
by: Iram Faqir Muhammad, et al.
Published: (2023-01-01)

Risk for Cardiovascular Death Associated With Waist Circumference and Diabetes: A 9-Year Prospective Study in the Wan Shou Lu Cohort
by: Man Li, et al.
Published: (2022-04-01)

Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
by: Naim Shehadeh, et al.
Published: (2018-08-01)

Common Polymorphisms Linked to Obesity and Cardiovascular Disease in Europeans and Asians are Associated with Type 2 Diabetes in Mexican Mestizos
by: Angélica Saraí Jiménez-Osorio, et al.
Published: (2019-02-01)

International Variability of Renal and Cardiovascular Outcomes and Mortality in Patients with Type 2 Diabetes Mellitus in Europe
by: Stefanie Thöni, et al.
Published: (2023-04-01)

Editorial: Advanced Cardiovascular Imaging in Diabetes
by: Fritz Schick, et al.
Published: (2022-03-01)

Type 2 diabetes: basic clinical and laboratory parameters and risk of cardiovascular death
by: O D Rymar, et al.
Published: (2020-05-01)

Treatment of diabetes: Crossing to the other side
by: Nikitas P. Skliros, et al.
Published: (2016-09-01)

Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis
by: Dan Liu, et al.
Published: (2019-03-01)

Trends in predicted 10-year risk for cardiovascular diseases among patients with type 2 diabetes in Thailand, from 2014 to 2018
by: Sethapong Lertsakulbunlue, et al.
Published: (2023-04-01)

Pre-diabetes as an interdisciplinary problem: definition, risks, approaches to the diagnostics and prevention of type 2 diabetes and cardiovascular complications
by: O. L. Barbarash, et al.
Published: (2019-05-01)

Sodium-Glucose Cotransporter-2 Inhibitors Improve Cardiovascular Dysfunction in Type 2 Diabetic East Asians
by: Muhammad Afzal, et al.
Published: (2021-11-01)

Rethinking the role of pioglitazone in modern diabetology as a cardiorenoprotective agent
by: V. V. Salukhov, et al.
Published: (2022-06-01)

Diabetes and cardiovascular disease /
by: Johnstone, Michael T., et al.
Published: (2005)

Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus
by: M. Yu. Gorshunska, et al.
Published: (2013-06-01)

Relationship between liver and cardiometabolic health in type 1 diabetes
by: Emir Tas, et al.
Published: (2024-11-01)

Ten-year cardiovascular risk estimation in type 2 diabetes in Europe using the novel SCORE2-Diabetes model
by: G. G. Arabidze, et al.
Published: (2024-07-01)

Trends in direct health care costs among US adults with atherosclerotic cardiovascular disease with and without diabetes
by: Chintal H. Shah, et al.
Published: (2024-07-01)

Monocyte–lymphocyte ratio predicts cardiovascular diseases death in individuals with type 2 diabetes
by: Han Li, et al.
Published: (2025-01-01)

Metabolic and cardiovascular features of the course of type 2 diabetes mellitus in men with hypogonadism
by: T. Yu. Demidova, et al.
Published: (2022-06-01)

Average Clinician‐Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial
by: William B. White, et al.
Published: (2018-10-01)

Diabetic retinopathy predicts cardiovascular disease independently of subclinical atherosclerosis in individuals with type 2 diabetes: A prospective cohort study
by: Esmeralda Castelblanco, et al.
Published: (2022-11-01)

Symposium: Cardiovascular disease in women with diabetes. Aspects to consider of cardiovascular disease in women with diabetes
by: Carolina Gómez Martín
Published: (2021-11-01)

The effect of underlying inflammation on iron metabolism, cardiovascular risk and renal function in patients with type 2 diabetes
by: Fransina Ndevahoma, et al.
Published: (2021-08-01)

Improving Outcomes in Patients With Diabetes Mellitus
by: David Aguilar
Published: (2019-02-01)